Licenses

CEVEC out-licenses its technologies and know-how to pharmaceutical and biotech companies worldwide. Partners in all major markets have taken licenses including CAP and CAP-T Technologies for the production of a wide range of proteins and other biomolecules.
To meet the individual needs of every single license holder, CEVEC offers a flexible, customer friendly model that will be adopted to your individual objectives based on the following license structure:

1. Non-Exclusive „Research Only“ license for CAP and/or CAP-T including free evaluation phase (available for CMO´s, CRO´s, BioTechs, Academia/Governmental Organizations and Pharmaceuticals Companies).
2. Non-Exclusive „Research and Development“ license (including pre-clinical activitities up to excluding clinical phase I studies).
3. Non-Exclusive „Development Phase I-IV“ License for CAP and/or CAP-T.
4. Exclusive „Production“ License and/or Exclusive „Protein Development” Licenses.

If you want to discuss with us our flexible license options please contact us at: bizdev@cevec-pharmaceuticals.com